1. Home
  2. news

News

Featured
NewYorkBIO Responds to Proposed NIH Fu…
Read All About It

Latest News

NewYorkBIO, New York City Economic Development Corporation, & Empire State Development Partner to Launch New York Bio Connect
New York’s leading life science advocacy association and economic development organizations develop resource…
Statement on Behalf of Jennifer Hawks Bland on ORPHAN Cures Act
Statement on Behalf of Jennifer Hawks Bland, CEO of NewYorkBIO 
NewYorkBIO Responds to Most Favored Nation Executive Order
Statement on behalf of Jennifer Hawks Bland, CEO of NewYorkBIO on Most Favored Nation Executive Order
MidAtlantic Bio Angel and NewYorkBIO Forge Strategic Partnership for 2025
New York, NY (April 23, 2025) – Mid Atlantic Bio Angels Group (MABA) and NewYorkBIO announced today a…
Statement from Jennifer Hawks Bland on National Security Commission on Emerging Biotechnology Report
NewYorkBIO joins BIO in expressing our gratitude to NSCEB for their years-long work to examine and present…
Statement on Behalf of Jennifer Hawks Bland on Proposed Tariffs
Statement on Behalf of Jennifer Hawks Bland on Proposed Tariffs
NewYorkBIO Welcomes Brian Dershowitz as Vice President of Strategic Partnerships & Initiatives
NewYorkBIO Welcomes Brian Dershowitz as Vice President of Strategic Partnerships & Initiatives
Show More News
RSS feeds source logo StatNews StatNews
STAT+: FDA delays reviews for two drugs in new voucher program
01/16/2026
And more biotech news, brought to you by The Readout
STAT+: JPM Week 2026 is over. It was fantastic. Here’s why
01/16/2026
There were no blockbuster deals at #JPM26. That's part of what it made it so great.
Breaking down JPM 2026: the mood, the big interviews — and all the AI billboards
01/15/2026
STAT's Alex Hogan breaks down #JPM26 on STATus Report: the mood, the big interviews — and all the ...
STAT+: On Day 4 of JPM, a chat with Regeneron’s George Yancopoulos, an IPO forecast, and all eyes on J&J
01/15/2026
It's the last special edition of The Readout at #JPM26 — full of news and notes about biotech.
STAT+: Regeneron’s chief scientist on Trump’s drug pricing policy, gene therapy, and the problem with AI
01/15/2026
Regeneron's chief scientist, George Yancopoulos, has some thoughts about the use of AI in medicine.
STAT+: Novo Nordisk Foundation gives $850M to nonprofit to help commercialize research in Europe 
01/15/2026
The Novo Nordisk Foundation announced it was giving an additional $850 million to an institute to ...
STAT+: On Day 3 of JPM, pharma threads a needle with the White House, and Novo Nordisk has an eye on M&A
01/14/2026
Some analysts believe both the White House and drugmakers won in the standoff over drug prices. ...
STAT+: Secretive Project Prometheus takes VC Bob Nelsen beyond just health care
01/14/2026
Venture capitalist Bob Nelsen believes his latest AI project will be “one of the most important ...
STAT+: On Day 2 of JPM, Gilead lays outs it next test, a VC looks to raise funds, and one firm has FDA whiplash
01/13/2026
Day 2 at #JPM26: You’re back. We’re sort of back. We’re definitely not exhausted or delirious ...